Researchers compare GAD-7 with clinical identification as a means of anxiety screening among adolescent syncope patients.

LUMRYZ™ generated $50.4 million in sales in the fourth quarter, up 158% year-over-year, taking the full-year total to $169.1 million, in line ...

On October 16, 2024, LUMRYZ was additionally approved as a once-at-bedtime treatment for cataplexy or EDS in pediatric patients ... (drowsiness), fainting (syncope) and death.

There are many different types of musculoskeletal conditions. That means that there are also a variety of causes of pediatric musculoskeletal conditions. For example, some of these conditions may ...

Fainting or blacking out, also known as syncope, is a temporary loss of consciousness due to insufficient blood flow to the brain. Vasovagal syncope is the medical term for the most benign kind of ...

To our knowledge the use of a tilt table to ascertain the effect of a distended bladder and urgency in the orthostatic position in a patient with micturition syncope has not been reported.

Syncope is a frequent cause for emergency consultation and hospital admission; it is also an indicator of reduced survival rate among older adults. The differential diagnosis may be large, but ...

OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA ...

The incidence rate of pulmonary embolism-related hospitalizations in pediatric patients revealed that this outcome occurred infrequently; however, having acute PE raised the odds for in-hospital ...

A stress ECG revealed ST depressions in leads II, III, and aVF (approximately 0.2-0.3 mV), but no chest pain or syncope was observed in the patient during transthoracic echocardiography.